Hemostasis Today
NewsFeed
Headlines Hematology Health Medicine VTE ASH Plasma Donation
July, 2026
July 2026
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
Athma Dias: The Diagnostic Challenge of Inherited Platelet Function Disorders
Athma Dias/LinkedIn
Jul 20, 2026, 19:41

Athma Dias: The Diagnostic Challenge of Inherited Platelet Function Disorders

Athma Dias, Medical Laboratory Scientist at Teaching Hospital Ratnapura, shared a post on LinkedIn about a recent article by Jonas Kaufmann et al. published in TH Open: Companion Journal to Thrombosis and Haemostasis, adding:

“A patient with a lifelong bleeding history.

  • Normal PT.
  • Normal APTT.
  • Normal platelet count.

The haemostasis laboratory has just begun its real work.

Platelet function disorders (PFDs) are among the most common inherited bleeding disorders worldwide yet they remain one of the most diagnostically underserved areas in clinical laboratory medicine.

The core problem? The test most laboratories use to screen them is inadequate.

The PFA Problem

The PFA-100/200 measures closure time the time for citrated whole blood under high shear to occlude a collagen/ADP or collagen/epinephrine membrane. It is simple, rapid, and automated.

But a comprehensive diagnostic accuracy study found:

  • Sensitivity for confirmed PFD: 19.5% (ADP cartridge) and 44.3% (EPI cartridge)
  • Specificity: 86% and 76% respectively

The PFA reliably detects von Willebrand disease and aspirin effect. For the broader spectrum of inherited PFDs dense granule deficiency, signalling pathway defects, glycoprotein abnormalities it misses the majority.

A negative PFA does not exclude a platelet function disorder.

The gold standard: Light Transmission Aggregometry (LTA)

LTA Born aggregometry remains the reference method for PFD diagnosis. Platelet-rich plasma is stirred at 37°C and exposed sequentially to agonists while light transmission is measured:

  • ADP — P2Y12 and P2Y1 receptor activation
  • Collagen — GPVI and α2β1 receptor pathway
  • Arachidonic acid — COX-1/thromboxane pathway; aspirin sensitivity
  • Ristocetin — GPIb-IX-V / von Willebrand factor interaction
  • Epinephrine — α2A-adrenergic receptor pathway

The pattern of aggregation responses across agonists defines the diagnosis:

  • Absent aggregation with all agonists except ristocetin: Glanzmann thrombasthenia (GPIIb/IIIa deficiency)
  • Absent ristocetin response only: Bernard-Soulier syndrome (GPIb-IX-V deficiency) or VWD
  • Selective ADP hypoaggregation: P2Y12 defect or drug effect

The Pre-Analytical Demands

LTA is one of the most pre-analytically sensitive tests in the laboratory:

  • PRP must be tested within 4 hours of collection platelet activation changes rapidly ex vivo
  • Patients must discontinue antiplatelet drugs 7–10 days before testing aspirin, NSAIDs, clopidogrel all confound results
  • Platelet count must be >100 × 10⁹/L in PRP for reliable light transmission baseline
  • Sample agitation during transport activates platelets pneumatic tube systems are contraindicated

LTA cannot be sent to a reference laboratory.

It must be performed by a trained MLS on a fresh sample, in real time.

That constraint is exactly what makes platelet function testing one of the most specialised and scientifically demanding disciplines in haemostasis.”

Title: Utility of the Platelet Function Analyzer in Patients with Suspected Platelet Function Disorders: Diagnostic Accuracy Study

Authors: Jonas Kaufmann, Marcel Adler, Lorenzo Alberio, Michael Nagler

Athma Dias: The Diagnostic Challenge of Inherited Platelet Function Disorders

 

Stay updated with Hemostasis Today.

Athma Dias bleeding disorders Blood Health Hematology Hemophilia Hemostasis Hemostasis News Hemostasis Today Jonas Kaufmann Lorenzo Alberio Marcel Adler Medicine Michael Nagler thrombosis
NewsFeed